TY  - GEN
AU  - Phillips,J T
AU  - O'Connor,P W
AU  - Havrdova,E
AU  - Hutchinson,M
AU  - Kappos,L
AU  - Miller,D H
AU  - Polman,C H
AU  - Lublin,F D
AU  - Giovannoni,G
AU  - Wajgt,A
AU  - Lynn,F
AU  - Panzara,M A
AU  - Sandrock,A W
TI  - Infusion-related hypersensitivity reactions during natalizumab treatment
SN  - 1526-632X
PY  - 2006///1226
KW  - Adrenal Cortex Hormones
KW  - therapeutic use
KW  - Adult
KW  - Antibodies, Monoclonal
KW  - adverse effects
KW  - Antibodies, Monoclonal, Humanized
KW  - Catecholamines
KW  - Drug Hypersensitivity
KW  - immunology
KW  - Female
KW  - Histamine H1 Antagonists
KW  - Humans
KW  - Infusions, Intravenous
KW  - Monitoring, Physiologic
KW  - standards
KW  - Multiple Sclerosis
KW  - drug therapy
KW  - Natalizumab
KW  - Time Factors
KW  - Treatment Outcome
N1  - Publication Type: Case Reports; Clinical Trial; Journal Article; Research Support, Non-U.S. Gov't
UR  - https://doi.org/10.1212/01.wnl.0000242629.66372.33
ER  -